MedPath

Exploratory research of the efficacy and safety with the enamel matrix derivative for anterior cruciate ligament reconstructio

Not Applicable
Conditions
anterior cruciate ligament injury
Registration Number
JPRN-UMIN000015497
Lead Sponsor
Hiroshima University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
19
Inclusion Criteria

Not provided

Exclusion Criteria

the patient who apply the contraindication of EMDOGAIN the patient who cannot obtaine written informed consent and had consciousness disorder or disorientation the general condition of the patient is considerably bad the patient with a serious liver damage the patient with a serious renal damage the female patient with the possibility with during the pregnancy or pregnancy the female patient under the nursing the patient with the past when is allergic to EMDOGAIN the patient who had perfomed the operation of the knee in addition, the patient who was disqualified by the chief physician for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath